SB-674042 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets OX1 receptor, OX1 receptor, OX2 receptor, and OX2 receptor.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.